Shandong Ruifeng Chemical Co., Ltd. (SHE:300243)
China · Delayed Price · Currency is CNY 14.21
-0.57 (-3.86%)
Nov 6, 2026, 3:04 PM CST
Shandong Ruifeng Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,172 | 1,966 | 1,999 | 1,772 | 1,830 | 1,852 |
Other Revenue | 3.04 | 3.04 | 2.25 | 3.83 | 1.85 | 6.7 |
| 2,175 | 1,969 | 2,001 | 1,776 | 1,832 | 1,858 | |
Revenue Growth | 8.73% | -1.59% | 12.66% | -3.03% | -1.45% | 42.75% |
Cost of Revenue | 1,815 | 1,682 | 1,719 | 1,468 | 1,537 | 1,517 |
Gross Profit | 360.35 | 286.8 | 282.03 | 308.24 | 294.44 | 341.48 |
Selling, General & Admin | 226.44 | 204.23 | 186.03 | 187.34 | 209.92 | 182.22 |
Research & Development | 8.11 | 8.57 | 9.01 | 14.6 | 6.43 | 4.31 |
Other Operating Expenses | -1.76 | -2.63 | 4.33 | 1.09 | 6.65 | 5.51 |
Operating Expenses | 232.03 | 210.32 | 204.56 | 202.61 | 223.19 | 193.12 |
Operating Income | 128.32 | 76.49 | 77.47 | 105.63 | 71.26 | 148.36 |
Interest Expense | -10.5 | -44 | -41.78 | -22.58 | -21.23 | -20.71 |
Interest & Investment Income | 0.86 | 3.8 | 3.53 | 4.07 | 1.11 | 5.39 |
Earnings From Equity Investments | 0.83 | -0.28 | -0.43 | 0.02 | - | - |
Currency Exchange Gain (Loss) | -0.5 | -0.5 | 5.37 | 3.15 | 6.99 | -1.61 |
Other Non Operating Income (Expenses) | -30.33 | -1.36 | -1.89 | 0.53 | -3.57 | -3.18 |
EBT Excluding Unusual Items | 88.69 | 34.16 | 42.27 | 90.82 | 54.56 | 128.26 |
Gain (Loss) on Sale of Assets | 0.61 | - | 0.02 | 0.19 | 0.19 | -0.05 |
Asset Writedown | -0.76 | - | -14.38 | -3.2 | -7.84 | - |
Other Unusual Items | 0.78 | -0.86 | 4.37 | 2.18 | 25.07 | -21.67 |
Pretax Income | 89.59 | 33.29 | 32.27 | 89.99 | 71.98 | 106.53 |
Income Tax Expense | 6.49 | 3.53 | 10.56 | 4.71 | 10.84 | 15.49 |
Earnings From Continuing Operations | 83.1 | 29.76 | 21.72 | 85.28 | 61.14 | 91.05 |
Minority Interest in Earnings | 0.44 | 0.57 | 0.36 | 0.02 | - | 1.82 |
Net Income | 83.54 | 30.33 | 22.08 | 85.29 | 61.14 | 92.87 |
Net Income to Common | 83.54 | 30.33 | 22.08 | 85.29 | 61.14 | 92.87 |
Net Income Growth | 583.80% | 37.40% | -74.12% | 39.51% | -34.17% | 8.80% |
Shares Outstanding (Basic) | 254 | 233 | 221 | 237 | 235 | 232 |
Shares Outstanding (Diluted) | 254 | 233 | 221 | 237 | 235 | 238 |
Shares Change | 16.99% | 5.69% | -6.82% | 0.76% | -1.25% | 3.22% |
EPS (Basic) | 0.33 | 0.13 | 0.10 | 0.36 | 0.26 | 0.40 |
EPS (Diluted) | 0.33 | 0.13 | 0.10 | 0.36 | 0.26 | 0.39 |
EPS Growth | 484.49% | 30.00% | -72.22% | 38.46% | -33.33% | 5.41% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 57.06 | 99.37 | -92.5 | -57.1 | -184.93 | -160.44 |
Free Cash Flow Per Share | 0.23 | 0.43 | -0.42 | -0.24 | -0.79 | -0.67 |
Dividend Per Share | 0.100 | 0.100 | 0.050 | 0.100 | - | 0.120 |
Dividend Growth | 100.00% | 100.00% | -50.00% | - | - | 0% |
Gross Margin | 16.56% | 14.57% | 14.10% | 17.36% | 16.08% | 18.38% |
Operating Margin | 5.90% | 3.89% | 3.87% | 5.95% | 3.89% | 7.98% |
Profit Margin | 3.84% | 1.54% | 1.10% | 4.80% | 3.34% | 5.00% |
Free Cash Flow Margin | 2.62% | 5.05% | -4.62% | -3.21% | -10.10% | -8.63% |
EBITDA | 225.2 | 171.63 | 170.31 | 163.45 | 124.54 | 189.04 |
EBITDA Margin | 10.35% | 8.72% | 8.51% | 9.20% | 6.80% | 10.17% |
D&A For EBITDA | 96.88 | 95.15 | 92.84 | 57.82 | 53.28 | 40.67 |
EBIT | 128.32 | 76.49 | 77.47 | 105.63 | 71.26 | 148.36 |
EBIT Margin | 5.90% | 3.89% | 3.87% | 5.95% | 3.89% | 7.98% |
Effective Tax Rate | 7.25% | 10.60% | 32.70% | 5.24% | 15.06% | 14.54% |
Revenue as Reported | 498.96 | 1,969 | 2,001 | 1,776 | 1,832 | 1,858 |